| Bioactivity | PKSI-527 is a new, highly selective plasma kallikrein inhibitor. PKSI-527 can suppress collagen-induced arthritis (CIA) by modifying the kallikrein-kinin system[1]. |
| Name | PKSI-527 |
| CAS | 128837-71-8 |
| Formula | C25H32ClN3O4 |
| Molar Mass | 473.99 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fujimori Y, et al. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice. Agents Actions. 1993 May;39(1-2):42-8. |
PKSI-527
CAS: 128837-71-8 F: C25H32ClN3O4 W: 473.99
PKSI-527 is a new, highly selective plasma kallikrein inhibitor. PKSI-527 can suppress collagen-induced arthritis (CIA)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.